[INVESTIGATION OF TREATMENT GOAL IN ALLERGEN IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS].

Abstract

BACKGROUND/OBJECTIVE:

As few reports are available on treatment goal for Japanese cedar pollinosis treated with allergen immunotherapy, therapeutic effect has to be assessed based on subjective symptoms in clinical practice. This research was conducted to investigate the informative treatment goal in clinical practice by using the results of TO-194SL phase III clinical trial.

METHODS:

In this investigation, correlation between total nasal symptom medication score (TNSMS), which was predefined as the primary endpoint, and secondary endpoints evaluated by severe symptom day, quality of life (QOL) score, and overall evaluation by subject, was firstly investigated. Based on the results, stratified analyses of the secondary endpoints to confirm relationships on the stratified results, TNSMS, and cedar season were performed.

RESULTS:

Correlation between TNSMS and evaluations which were severe symptom day, QOL score, and overall evaluation by subject was reasonably observed. TNSMS generally showed 3 or below (classified as mild) throughout the entire pollen season when these evaluations reached each threshold.

CONCLUSIONS:

The results of this investigation suggest that a few evaluation items would help patients to realize the therapeutic effects of allergen immunotherapy if they could be the treatment goal in clinical practice.

• Authors: Minoru Gotoh, Kimihiro Okubo, Yoshitaka Okamoto, Syuji Yonekura, Shinya Kaneko, Akiyoshi Konno
• Journal: Arerugi = [Allergy] (Arerugi) 2018 Vol. 67 Issue 7 Pg. 938-947 ISSN: 0021-4884 [Print] Japan
• PMID: 30146626 (Publication Type: Journal Article)

Chemical References

• Allergens

Topics

• Allergens
• Cryptomeria
• Desensitization, Immunologic
• Goals
• Humans
• Pollen
• Quality of Life
• Rhinitis, Allergic, Seasonal (therapy)